1 / 30

OPPORTUNISTIC FUNGAL INFECTIONS

OPPORTUNISTIC FUNGAL INFECTIONS. Smilja Kalenic, MD, PhD Clinical Hospital Centre Zagreb, Croatia. LEARNING AND PERFORMANCE OBJECTIVES to learn about the most frequent opportunistic fungi and to understand main risk factors for developing infection

Thomas
Download Presentation

OPPORTUNISTIC FUNGAL INFECTIONS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. OPPORTUNISTIC FUNGAL INFECTIONS Smilja Kalenic, MD, PhD Clinical Hospital Centre Zagreb, Croatia

  2. LEARNING AND PERFORMANCE OBJECTIVES • to learn about the most frequent opportunistic fungi and to understand main risk factors for developing infection • to be able to predict the most probable agent of invasive fungal infection in a particular compromised patient state and to be able to act preventively

  3. FUNGI • EUCARIOTIC ORGANISMS • TWO BASIC FORMS: - YEASTS - MOLDS

  4. MYCOSES 1. SUPERFICIAL 2. CUTANEOUS 3. SUBCUTANEOUS

  5. MYCOSES 4. ENDEMIC (PRIMARY, SYSTEMIC): Histoplasma capsulatum, Coccidioides immitis, Blastomyces dermatitidis, Paracoccidioides brasiliensis

  6. MYCOSES 5.OPPORTUNISTIC endogenous - Candida (different species) - Pneumocystis carinii (?)

  7. MYCOSES 5.OPPORTUNISTIC exogenous - Cryptococcus neoformans - Aspergillus (different species) - Zygomycetes - MANY OTHER FUNGI

  8. Candida albicans and other Candida species • Harmless inhabitants of the skin and mucous membranes of all humans • Normal immune system keeps candida on body surfaces

  9. MAIN DEFENSE MECHANISMS AGAINST CANDIDA I. • skin and mucous membranes integrity • presence of normal bacterial flora

  10. MAIN DEFENSE MECHANISMS AGAINST CANDIDA II. • phagocytosis • killing, mostly in polymorphonuclear cells, less in macrophages • T-cells (CD4)

  11. THE MOST IMPORTANT RISK FACTORS 1. Neutropenia 2. Diabetes mellitus 3. AIDS 4. SCID 5. Myeloperoxidase defects 6. Broad-spectrum antibiotics

  12. THE MOST IMPORTANT RISK FACTORS 7. Indwelling catethers 8. Major surgery 9. Organ transplantation 10. Neonates 11. Severity of any illness 12. Intravenous drug addicts

  13. CLINICAL FORMS OF CANDIDIASIS 1. Cutaneous and mucosal candidiasis

  14. CLINICAL FORMS OF CANDIDIASIS 2. Invasive (systemic, disseminated, hematogenous) candidiasis

  15. INVASIVE CANDIDIASIS • Usually begins with candidemia (but in only about 50% of cases candidemia can be proven) • If phagocytic system is normal, invasive infection stops here

  16. INVASIVE CANDIDIASIS • If phagocytic system is compromised, infection spreads to many organs and causes focal infection in these organs • mortality of candidemia is 30-40%

  17. DIAGNOSIS OF INVASIVE CANDIDIASIS • Gram stain and isolation from blood, CSF or peritoneal fluid • isolation and/or pathology positive of organ involved • other tests are of lower significance for the diagnosis

  18. EPIDEMIOLOGY Although candidiasis is endogenous in most cases, cross infections are described, especially in intensive care unit patients.

  19. Pneumocystis carinii • Present in lungs of many mammals, including humans, in persistent but harmless infection

  20. Pneumocystis carinii • Main defense mechanism is T-cell mediated • causes interstitial pneumonitis in compromised patients • treatment and prevention: cotrimoxasole or pentamidine

  21. Cryptococcus neoformans • Occurs worldwide in soil and in bird droppings • Prominent feature: thick polysaccharide capsule, which causes evasion from phagocytosis

  22. MAIN DEFENSE MECHANISMS AND PATHOGENESIS • T-cells responsible for defense • Cryptococcus reaches humans by inhalation of aerosolized yeast cells

  23. CHRONIC MENINGITIS IN AIDS-PATIENTS • The most important clinical syndrome • treatment: amphotericin B+/-flucytosine • recurrence prevention: fluconazole

  24. EPIDEMIOLOGY OF CRYPTOCOCCOSIS Infection is always exogenous, is not transmitted from human to human

  25. Aspergillus species • Aspergilli are worldwide occurring saprophytes, living in soil and on plants; they have small conidia that form aerosols

  26. Main defense mechanism is • phagocytosis • Main risk factors are • hematological malignancy, • bone marrow transplantation • and corticosteroid therapy

  27. The most frequent syndromes are: - aspergilloma - invasive aspergillosis (high mortality rate) Treatment: amphotericin B, itraconazole, flucytosine and surgery Prevention: avoid exposure to conidia (new buildings in the hospital!)

  28. ZYGOMYCETES • Zygomycetes are ubiquitous saprophytes • main host defense is phagocytosis • main risk factors are diabetes, hematological malignancies, corticosteroid therapy

  29. Major clinical syndrome is: Rhinocerebral mucormycosis (infection of nasal passages, sinuses, eyes, cranial bones and brain) Treatment: surgery and amphotericin B Prognosis: very poor

  30. OPPORTUNISTIC FUNGAL INFECTIONS ARE: • difficult to diagnose • difficult to treat • difficult to prevent • more and more frequent • a great challenge for a future work in all fields

More Related